| Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial 2025 · Silexan · Adults of any sex with mild-to-moderate, single or recurrent major depressive disorder | 80 mg | 8 weeks | 170 |
| Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine 2014 · Silexan 80 mg/d group · Adults with generalized anxiety disorder (GAD) according to DSM-5 criteria and a Hamilton Anxiety Scale total score ≥18 points | 80 mg | 10 weeks | 135 |
| Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial 2019 · Spicae aetheroleum · Adults aged 18–75 with uncomplicated acute bronchitis | 450 mg | 10 days | 131 |
| Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine 2014 · Silexan 160 mg/d group · Adults with generalized anxiety disorder (GAD) according to DSM-5 criteria and a Hamilton Anxiety Scale total score ≥18 points | 160 mg | 10 weeks | 121 |
| Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers 2021 · Silexan 80 mg · Healthy volunteers | 80 mg | 7 days | 50 |
| The efficacy of oral Lavandula angustifolia Mill. essential oil on menopausal symptoms, serum lipid profile, and cortisol concentration in postmenopausal women: A triple-blind, randomized, controlled trial 2024 · LEO group · Postmenopausal women aged 50–65 years with a Green scale score of 15–42 | 80 mg | 60 days | 36 |
| The effect of lavender herbal tea on the anxiety and depression of the elderly: A randomized clinical trial 2020 · intervention group · Elderly adults; specific age range and health condition not reported | 4 g | 2 weeks | 30 |
| The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial 2024 · LEO group · Women aged 15–49 using combined oral contraceptives, with a high negative-to-positive emotional score and without depression or a recent diagnosis of psychological health problems | 80 mg | 8 weeks | 30 |
| The effect of lavender herbal tea on the mental health of individuals with misophonia: A randomized controlled trial 2026 · experimental group · Adults aged 18 and over diagnosed with misophonia | 4 g | 2 weeks | 30 |
| Lavender improves fatigue symptoms in multiple sclerosis patients: A double-blind, randomized controlled trial 2022 · intervention group · Adults with relapsing-remitting multiple sclerosis and fatigue (MFIS ≥25), aged 18 years or older | 1.8 g | 60 days | 24 |
| A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression 2020 · Lavender (L. angustifolia; Group A) · Adults aged 18–65 with mild to moderate depression | 2 g | 8 weeks | 15 |
| Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial 2010 · Silexan · Adults with anxiety disorder not otherwise specified, with HAMA total score ≥18 and PSQI total score >5 | 80 mg | 10 weeks | — |
| Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial 2015 · Silexan group · Out-patients with anxiety-related restlessness and disturbed sleep, diagnosed with restlessness (ICD-10 R45.1), HAMA total score ≥18 and scores ≥2 for HAMA items Tension and Insomnia | 80 mg | 10 weeks | — |
| Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial 2016 · Silexan · Adults with mixed anxiety and depressive disorder (MADD), HAMA score ≥18, and at least moderately severe anxious and depressed mood | 80 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 10 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 10 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 40 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 40 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 80 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 80 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 160 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 160 mg | 10 weeks | — |
| Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect 2019 · Silexan · Patients treated for anxiety, with disturbed sleep assessed in the study | 80 mg | 10 weeks | — |
| Tavipec in acute rhinosinusitis: a multi-centre, doubleblind, randomized, placebo-controlled, clinical trial 2019 · Tavipec group · Adults with acute viral rhinosinusitis | 450 mg | 7 days | — |
| Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial 2020 · group B · People with major depressive disorder accompanied by anxious distress; age and sex not reported | 10 mL | 6 weeks | — |
| Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging 2014 · Silexan · Healthy men aged 20–34 years | 160 mg | 66 days | 25 |
| No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination 2014 · Silexan · Healthy premenopausal women aged 18–38 years using a combined oral contraceptive | 160 mg | 4 weeks | 24 |
| Lavender and metformin effectively propagate progesterone levels in patients with polycystic ovary syndrome: A randomized, double-blind clinical trial 2024 · lavender · Females aged 18 to 45 with polycystic ovary syndrome | 500 mg | 90 days | — |